Vision
Meet the Team.
These are the the people behind PrivMed® and find out what's their motivation to change the healthcare systems
"Inspired by personalised medication, changing my son's life to a better one."
"I am enthusiastic about establishing a new system for high-quality healthcare services."
At the center of our work is the human as a patient.
Through sustainable design solutions we improve the future way of understanding, producing and taking medication.
​
PrivMed® saves ressources and is our take on sustainable medication.
​
Intelligent design deals with the problems and challenges of our time. PrivMed® is our answer to an urgent need of personalized medication. Age, gender, bodyweight and height are rarely considered when medication is subscribed. Unified boxed medication is the norm. Tailormade medication saves valuable pharma material and packaging and therefore is the necessary step to a sustainable medication.
​
The team of PrivMed®
Better health – through 100% individually dosed medication!
When Timo, the son of founder Ingo Krause, fell ill with ADHD at the age of seven, it was the beginning of a long odyssey of treating his symptoms with various medications from the field of psychotropic drugs.
​
“We hesitated for a long time, but without medication, it would not have been possible for him to attend school at all. When he started taking medication things started to improve at school, and Timo was also much better, because suddenly he was able to concentrate and control his social behaviour.
Ingo Krause
Better health – through 100% individually dosed medication!
However, there was a fundamental problem with the medication: as is common with pharmaceuticals, special dosages for children are rarely available.
​
Clinical studies are only carried out with adult patients. Children, pregnant women or the elderly, who have very special needs, do not figure in the reference groups.
The available dosages of 20, 40, 60 or 80 mg prescribed by the doctor were completely unsuitable for Timo’s treatment, as almost every milligram of psychotropic drugs can cause changes. Moreover he was of an age when children grow quickly, which meant that his body weight changed too. The dosage had to be constantly adjusted.
​
When we started to divide the standard doses in order to be able to react to his daily condition, we very quickly questioned why it was not possible to get personalised doses in the 21st century.
​
At this time my company, kg-pharma, had already been internationally successful in the field of R&D pharmaceutical tablet presses for 12 years.
​
These are what pharmaceutical manufacturing companies use to prepare for the mass production of tablets.
However, this “standard dose medication” reflects the existing treatment system of permanent, often harmful overdosing of drugs, especially in children, but also the chronically ill and many other patients.
“It was then that I realised for the first time that every patient in this world must have the right to personalised medication.”
That was when PrivMed® was born.
Das Maschinenbaustudium an der HTWG Konstanz mit dem Schwerpunkt auf die Konstruktion und Entwicklung war für mich der Start, meine Leidenschaft zum Beruf zu machen. Auf meine Tätigkeit in der freien Wirtschaft folgte daher auch mein Wunsch nach Selbstständigkeit. Ich gründete ein Ingenieurbüro mit der Absicht, die Verantwortung für komplexe Projekte und Problemlösungen zu haben. Je herausfordernder ein Projekt war, desto begeisternder packte ich es an. Ich bemerkte, dass es das Diffizile war, das mich voranbrachte. Scheinbar unlösbare Anfragen und Problemstellungen von Kunden weckten in mir besonderes Interesse und den notwendigen Tatendrang.
René Manigk
Mit PrivMed® lösen wir das Problem der Überdosierung.
So kam es, dass der Anruf Ingo Krauses im November 2018 Begeisterung in mir weckte. Er erzählte mir von seiner Projektidee PrivMed® und steckte mich mit seinem innovativen Denken an. Für mich stand sofort fest, dass ich dieses außergewöhnliche Projekt zusammen mit ihm umsetzen möchte. Ab diesem Zeitpunkt war ich für die technische Umsetzung verantwortlich. Dabei profitierten wir von der langjährigen Erfahrung Ingo Krauses im pharmazeutischen Maschinenbau genauso wie von meiner pharmazeutischen Unwissenheit. Denn dadurch konnten wir klassische Denkmuster durchbrechen und innovative Ideen entwickeln. So ist die PrivMed® eine Maschine mit einem völlig neuen Funktionsprinzip zur Herstellung individueller Tabletten, die sich von herkömmlichen Tablettenpressen gänzlich unterscheidet.
​
Die PrivMed® ist für mich eine unglaubliche Zukunftsvision, die täglich wächst und nun dank unserer Tatkraft zur Realität wurde. Eine Bereicherung für mich, für die pharmazeutische Industrie und letztlich ein unglaublicher Gewinn für die individuelle Gesundheit des Menschen.
René Manigk, Founder und CTO PrivMed®